{"name":"EsoCap AG","slug":"esocap-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ESO-101","genericName":"ESO-101","slug":"eso-101","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ESO-101","genericName":"ESO-101","slug":"eso-101","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQa1ZjNFoxUWJnTFZrN3N4NHh4TG1XWUtXVkRCQ2ZWRWpWNlZ4ZlFMdGR1cFFTYzM3UXIwNjBUbkVpdGV2dzUwejBwTUxHQ3hiM2FZRW9xX3Bnbl9HUXlScnZaWWhDQmI2aWdvcE9yazk0QWRiLXo0M3JBbkJSVmJ1VjV2NHQwcXZfUzBuS1c4U1ZYek55dmVjZlFsdm1zbkhadUFVY2pYVkJfalpaMnV6SE1ZY0NPWDFDbWdVVTl0emI4clotS1lHaG5rZGhLUjJ3TWNqNzYxTUsxZEJTRlhwVWpvdzUtNXhaSUI0bzRuMHVwX3Z1?oc=5","date":"2025-05-15","type":"pipeline","source":"prnewswire.com","summary":"Eosinophilic Esophagitis Market Set to Surge as New Research Unveils Breakthrough Treatments | DelveInsight - prnewswire.com","headline":"Eosinophilic Esophagitis Market Set to Surge as New Research Unveils Breakthrough Treatments | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxObEV6S0p1c2c1RlpmVHF5TWJsTldWLXdmXzFqbUJQeV9GbDMwdThFUVA4TGdVVDFlZXhwd2FyM1pYYm1PZmNia0YxMUx0RWJJUC1ETFBFYm15MlJGTV84T2d6cWltMllFX3NCMDJxNGVTclpSTF9wUms5NFNrS1huT0pJTFF0a2RYSjhuOVdCcEhXcGRjanc?oc=5","date":"2025-01-15","type":"pipeline","source":"BioWorld News","summary":"Esocap effectively treats eosinophilic esophagitis - BioWorld News","headline":"Esocap effectively treats eosinophilic esophagitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFBLd3BFZURoRjZIMWpOVE5zODMzNlVtU2o2REdOSDRhYUI1cF9URGtqR0VrVlp1c3JMdTVSVGN2cHo3NFRsVTlscVRnWTN6OTF4aHJhbGF6RXlVTkxwV25UVV9ZVQ?oc=5","date":"2024-12-16","type":"trial","source":"Wiley Online Library","summary":"Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis - Wiley Online Library","headline":"Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQNzUwTHJCMUJFWDhOV01SWWU1ZHNjbDVtbWpXUVpySkRMQkZQSS0wTnZKSnFkcmtnOHBRV2REc29jU1ZuQkZua2haOFdhOEtpZ1ZRdGNoVGNkRk5RVGJtNE5abEVHaVhTRlkxb2RIUUVYUUk4MWdhYzJLVThQeXk3eWVjSjJxbVdDd0NDTlBjQnVIeURMV3c?oc=5","date":"2024-02-28","type":"pipeline","source":"openPR.com","summary":"Eosinophilic Esophagitis Market Analysis by Size, Growth - openPR.com","headline":"Eosinophilic Esophagitis Market Analysis by Size, Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNS08wb001ME1uY2JCZ05YeEdmY0JBSjdRczROeF83U29GT2luUzBwZDVidWJUYTJ1RVItNmtXNGFWcFNRY3pYS1N5emc1S0EySGItMzBVSXowaG9GMUJ1VnpfMTBRcmNRdGhSWUVrOWRaSFNlcXhpbEM3VDFYYnNaUXZjYVBRMlNTbFpNUHlnMzNrTm5MTGc?oc=5","date":"2023-09-28","type":"pipeline","source":"Yahoo Finance","summary":"Eosinophilic Esophagitis Market to Show Positive Growth by 2032, Examines DelveInsight | Key Companies - Bristol Myers Squibb, Ellodi, AstraZeneca, Kyowa Kirin, Allakos, Pfizer, Revolo, EsoCap AG, Nex","headline":"Eosinophilic Esophagitis Market to Show Positive Growth by 2032, Examines DelveInsight | Key Companies - Bristol Myers S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNWUphRDdmZGJZTlo1N3BVNGJrVXRmekdaSmpYTVZ2dTVLYlJKZkpCaGwwUHVxQXI1bVc2Tl9yNkJpOF82X090OTZ3UjZUMzczZlQ5S0k5UzVzY2RPOWhrWFdfak40d29iRndzODV0N0lDUjF3czVHcGY3N1h5ODkya0dHVzl0VmJtbXUybFpnUm5FbHBl?oc=5","date":"2023-03-17","type":"pipeline","source":"openPR.com","summary":"Complete guide to Eosinophilic Esophagitis Market 2023: - openPR.com","headline":"Complete guide to Eosinophilic Esophagitis Market 2023:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQM3pDa2t5NWU1c1JCQ0JwbmppVlpVMU9Ha19vRjUzY2dVVjJwUFUySWM1LXBJMW16T1UxYTRvV2JwZTcxd210MEF0TEp6T2U5ZjM4eDZjX1RkblNBazVBT3FYenpfRDdmelA5My1EMzYzX2dxN3pWVnA5RFNYRjhvcGVfYkFTUlpobTRuSUVNWjRQRmtnLXZTM3c0V1dLeTRUM0JoQllsRVg0cTlaWTZrYVhHUlBBX1N0Q21aZVR1RENuczhWT3BpUGMzQjZudnpCSHlZWVFZSWdra3k2Rnc?oc=5","date":"2022-07-25","type":"trial","source":"prnewswire.com","summary":"Eosinophilic Esophagitis Clinical Trial Pipeline Analysis of 15+ Companies by DelveInsight - prnewswire.com","headline":"Eosinophilic Esophagitis Clinical Trial Pipeline Analysis of 15+ Companies by DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}